| |
 |
Altair
Nanotechnologies, Inc. (NasdaqSC: ALTI) |
 |
Dear Readers,
Pardon the brevity of this message but in the interests of urgency
we wanted to keep it short and sweet. News like this needs
no further elaboration.
A company we first profiled quite some time ago, Altair Nanotechnologies,
Inc. (NasdaqSC: ALTI), has recently published intriguing news
regarding nanotechnology, the foundation of its business plan.
Included in this news are such encouraging nuggets as the U.S.
House of Representatives earmarking $2.36 billion over
three years to fund nanotechnology research and a high ranking
U.S. Senator touring the Altair facility. (See news excerpts
below)
Our profile
(click here), published nearly a year ago, will give
you a brief primer on the company. Additionally, we published
a report
on nanotechnology by Analyst Randy Lewis last summer (click
here).
We strongly encourage you to read them both.
For Current News & Stock Price info on ALTI: click
here
|
**Breaking
News** |
|
Altair Nanotechnologies
President Interviewed by
Chemical Market
Reporter;
Altair Pigment
Process Continues to Generate International
and Domestic
Interest
Tuesday May 13,
2:32 pm ET
RENO, Nev., May 13, 2003
(PRIMEZONE) -- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News)
announced today that an interview with the company's President,
Dr. Rudi E. Moerck, has been published in the April 28, 2003,
issue of Chemical Market Reporter, a publication dedicated to
providing the latest chemical business news, including financial
reporting and analysis, market updates, new technology, legislative
and regulatory issues, plus a comprehensive round-up of special-interest
areas. To read the entire release: Click
Here
Altair Nanotechnologies
Reports Passage of
Science Committee
Legislation by
U.S. House of
Representatives
Friday May 9, 10:31
am ET
House Earmarks
$2.36 Billion Over Three Years to Fund
Nanotechnology
Research
RENO, Nev., May 9, 2003 (PRIMEZONE)
-- Altair Nanotechnologies Inc. (NasdaqSC:ALTI - News)
reported today that the U. S. House of Representatives passed
the Science Committee legislation which authorizes a national
nanotechnology research and development program. H.R. 766, the
Nanotechnology Research and Development Act of 2002, authorizes
$2.36 billion over three years for several Federal agencies.
According to Science Committee
Chairman, Sherwood Boehlert, who supported the bill, the U.S.
government needs to step up funding for basic research that could
lead to commercial development. He went on to note that it is
one of the most promising and exciting fields in science today.
The Senate is expected to take up a similar measure soon and the
measure has White House support.
"The passing of H.R. 766 could
not be timelier," said Altair Nanotechnologies President Rudi
E. Moerck. "Over the last several years Altair has developed patented
processes that provides for the economic manufacturing of a wide
range of a high purity nanomaterials ranging from lithium titinate
spinel, titanium dioxide, stabilized zirconium dioxide to lanthanum
strontium manganates. We are positioned to take advantage of the
significant new development opportunities."
To read the entire release: Click
Here
|
StockUpTicks
- Your Small-Cap Discovery Zone |
|
Want
to feature YOUR company to over 1 MILLION investors?
Click
here to
learn more about our programs or email us directly at info@stockupticks.com
Stockupticks
Safe Harbor Statement: Statements contained in this document,
including those pertaining to estimates and related plans, potential
mergers and acquisitions, estimates, growth, establishing new markets,
expansion into new markets and related plans other than statements
of historical fact, are forward-looking statements subject to a
number of uncertainties that could cause actual results to differ
materially from statements made. StockUpTicks.com is a property
of Market Pathways Financial Relations Incorporated (MP).
MP provides no assurance as to the subject company's plans or ability
to effect any planned and/or proposed actions. MP has no first-hand
knowledge of management and therefore cannot comment on its capabilities,
intent, resources, nor experience and makes no attempt to do so.
Statistical information, dollar amounts, and market size data was
provided by the subject company and related sources believed by
MP to be reliable, but MP provides no assurance, and none is given,
as to the accuracy and completeness of this information.
Disclaimer:
StockUpTicks.com is a property of Market Pathways Financial Relations
Incorporated (MP). The information, opinions and analysis
contained herein are based on sources believed to be reliable
but no representation, expressed or implied, is made as to its
accuracy, completeness or correctness. Past performance
is no guarantee of future results. This report is a paid advertisement
and is for information purposes only and should not be used as
the basis for any investment decision. MP
was previously paid 15,000 shares of ALTI stock by Altair (Sept.
2002) and Altair has committed to pay MP an additional 33,760
shares for work previously performed and for other advertising
services. This constitutes a conflict of interest as to
MP’s ability to remain objective in its communication regarding
the subject company. Write or call MP for detailed disclosure
as required by Rule 17b of the Securities Act of 1933/1934.
MP is not an investment advisor and this report is not investment
advice. This information is neither a solicitation to buy nor
an offer to sell securities but is a paid advertisement.
Information contained herein contains forward-looking statements
and is subject to significant risks and uncertainties, which will
affect the results. The opinions contained herein reflect
our current judgment and are subject to change without notice.
MP and/or its affiliates, associates and employees from time to
time may have either a long or short position in securities mentioned.
Information contained herein may not be reproduced in whole or
in part without the express written consent of Market Pathways
Financial Relations Incorporated.
|
|
